STEARIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
283.0 5.0 0 2 40.0 16 0.94
CAS
57114
UNII
4ELV7Z65AP
SYNONYMS
ZINC ID(s)
Availability
Present in 82 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
PPARD Peroxisome proliferator-activated receptor delta Unclassified / Unclassified
PPARA Peroxisome proliferator-activated receptor alpha Transcription Factor / Nr

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Functions of Stearic Acid

Misc - Miscellaneous

Regulatory Status of Stearic Acid

Gras - Generally recognized as safe.

Dosages

Route Formulation Per Unit Dose
Buccal Tablet 5MG
Buccal/sublingual Tablet 6MG
Implantation Pellet 0.2MG
Oral Capsule 52MG
Oral Capsule, Coated, Soft Gelatin 3MG
Oral Capsule, Delayed Action 3MG
Oral Capsule, Extended Release 3.23MG
Oral Capsule, Hard Gelatin 15MG
Oral Capsule, Sustained Action 21MG
Oral Powder, For Suspension 24.06%
Oral Syrup
Oral Tablet 72MG
Oral Tablet (immed./comp. Release), Coated 5.3MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 15MG
Oral Tablet, Coated 42.4MG
Oral Tablet, Controlled Release 1.6MG
Oral Tablet, Delayed Action 15MG
Oral Tablet, Delayed Action, Enteric Coated 16MG
Oral Tablet, Enteric Coated Particles 5MG
Oral Tablet, Extended Release 180MG
Oral Tablet, Orally Disintegrating 0.47MG
Oral Tablet, Sugar Coated 0.9MG
Oral Tablet, Sustained Action 187.5MG
Oral Tablet, Sustained Release, Film Coated 9MG
Oral-21 Tablet 1MG
Oral-28 Tablet 1MG
Subcutaneous Implant 1.04MG
Sublingual Tablet 5.05MG
Topical Cream, Augmented 3%
Topical Cream, Emulsion, Sustained Release 16%
Topical Emulsion, Aerosol Foam 8%
Topical Emulsion, Cream 22.5%
Topical Lotion 3.5%
Topical Ointment 15%
Topical Solution
Topical Suspension 1.75%
Vaginal Emulsion, Aerosol Foam 4%
Vaginal Emulsion, Cream 14%
Vaginal Tablet 60MG

More Information

Usage Over Time

Comments